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Abstract
Background: Cardiovascular diseases (CVD) cause 1.8 million premature (<75 years) death annually in Europe. The
majority of these deaths are preventable with the most efficient and cost-effective approach being on the population
level. The aim of this position paper is to assist authorities in selecting the most adequate management strategies to
prevent CVD.
Design and Methods: Experts reviewed and summarized the published evidence on the major modifiable CVD risk
factors: food, physical inactivity, smoking, and alcohol. Population-based preventive strategies focus on fiscal measures
(e.g. taxation), national and regional policies (e.g. smoke-free legislation), and environmental changes (e.g. availability of
alcohol).
Results: Food is a complex area, but several strategies can be effective in increasing fruit and vegetables and lowering
intake of salt, saturated fat, trans-fats, and free sugars. Tobacco and alcohol can be regulated mainly by fiscal measures and
national policies, but local availability also plays a role. Changes in national policies and the built environment will
integrate physical activity into daily life.
Conclusion: Societal changes and commercial influences have led to the present unhealthy environment, in which
default option in life style increases CVD risk. A challenge for both central and local authorities is, therefore, to
ensure healthier defaults. This position paper summarizes the evidence and recommends a number of structural
strategies at international, national, and regional levels that in combination can substantially reduce CVD.
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Introduction
This position paper summarizes the available evidence
of the effect of population level changes on risk factors
for cardiovascular diseases (CVD). Our aim is to assist
national authorities in selecting the most adequate
management strategy to prevent CVD. The recommen-
dations address the established risk factors for CVD,
and will be valid for some other non-communicable
diseases sharing the same risk factors, particularly
type 2 diabetes, lung diseases, and common cancers.1
The evidence for changes in risk factors on a
population level is based on best available scientific evi-
dence. Recommendations for individual prevention
approaches are given elsewhere.2,3
The burden of CVD
CVD remain the main cause of death in Europe leading
to more than 4.3 million deaths in 2005 – every second
death.4 Over 40% are premature, occurring before the
age of 75 years (1.8 million), and 54% occur in women.
Coronary heart disease (CHD) and stroke are the com-
monest forms of CVD constituting 22% (1.9 million)
and 14% (1.2 million) of all deaths, respectively. CHD
is responsible for 20% of all deaths before age 75.
CVD mortality rates have decreased steadily in
the European Union (EU) since the 1980s, and in
Central Europe since the 1990s.5,6 A worrying
upward pattern seen in Commonwealth of
Independent States (CIS) has recently changed into
a decline, but still there is a huge variation in CVD
mortality across Europe (Figure 1). Disability-
adjusted life years (DALYs) provide an aggregate
of years lost due to premature death and years of
healthy life lost due to disability, and in 2005 CVD
accounted for 34 million DALYs (23% of total).5
Age-adjusted DALYs in Eastern Europe were three
times higher than in Southern Europe.
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Figure 1. Age- and sex-adjusted mortality rates (per 100,000) from CVD in Europe in the years 1980–2009. The European region
includes all European countries including the CIS countries. The CIS countries comprises: Armenia, Azerbaijan, Belarus, Kazakhstan,
Kyrgyzstan, Republic of Moldova, Russian Federation, Turkmenistan, Tajikistan, Ukraine (still not an official member), and Uzbekistan.
Source: World Health Organization.6
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Unlike mortality trends, hospital discharge rates for
CVD (acute coronary syndromes and stroke) have
increased in the majority of European countries.
Recently this has tended to stabilize in EU, but
increased rampantly in CIS (Figure 2). CVD hospital
discharge rates in Lithuania are fivefold higher than in
Cyprus. Overall CHD hospital discharges are increas-
ing in Europe due to the more recent EU member coun-
tries and CIS. Other forms of CVD (including heart
failure) account for more than half of hospital dis-
charges in the majority of European countries. The
changing and diverse CVD patterns are in line with
observed changes of life style factors dealt with in the
present paper.7–10
In 2006, total CVD costs in EU exceeded 190 billion
Euros, including 110 billion Euros for health care (54%
to inpatient care, 28% to medications, and 18% other).
This represents an average expenditure of 223 Euros
per capita per annum or 10% of total health care
costs – ranging from 5% in Cyprus, Denmark, and
Luxemburg to 17% in Poland.11
Risk factors
Since the 1960s, multiple risk factors for CVD have
been identified.2,5 Seven major modifiable risk factors –
tobacco, high blood pressure, high cholesterol, alcohol,
low fruit and vegetable intake, physical inactivity, high
blood pressure, high cholesterol, and obesity – account
for over 60% of total DALYs in Europe.5 As high
cholesterol, blood pressure, and obesity are strictly
linked to unhealthy diet and physical inactivity, the
present position paper will focus on diet, smoking,
physical inactivity, and alcohol, which all can be modi-
fied through population-based strategies.
Healthy diets are characterized by high intakes of
fruits, vegetables, legumes, fibre, whole grains, nuts,
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Figure 2. Age- and sex-adjusted hospital discharge rates (per 100,000) for CVD in Europe in the years 1980–2009. The European
region includes all European countries including the Commonwealth of Independent States (CIS) countries. The CIS countries
comprises: Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Republic of Moldova, Russian Federation, Turkmenistan, Tajikistan,
Ukraine (still not an official member), and Uzbekistan. Source: World Health Organization.6
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vegetable oils, and fish; whereas unhealthy diets are
characterized by high intakes of salt, red meat, pro-
cessed meat, saturated fat, trans-fat, refined grains,
and refined sugars. Unhealthy diets greatly increase
CVD incidence and premature mortality.3 Key prob-
lems are high salt intake,12 sugar sweetened beverages,
and saturated fat,13–15 each accounting for 10–15% of
calories consumed by youth.16 Smoking and passive
smoking are among the best-established risk factors
for CVD and premature mortality.2 Physical inactivity
increases CVD and all-cause mortality.2,17 Recently
even low-level physical activity has been shown benefi-
cial for health,18 making ‘sedentarism’ (e.g. TV viewing,
PC using) an independent risk factor.19,20 Both old and
new media and systems of communication promote
more sedentary habits and, frequently, imply higher
consumption of snacks and junk food. Excess alcohol
consumption is a risk factor for CVD.21 Light alcohol
consumption may be protective;22 however, no con-
trolled studies with sufficient long-term data exist,23
and there are concerns about publication bias in studies
analysing lower levels of intake (<50 g/day).21
Who is responsible? Prevention
approaches and arenas
Rose made the seminal argument for a focus on popu-
lation level strategies for disease prevention.24 He iden-
tified that a small shift in the risk of disease across a
whole population can lead to greater reductions in dis-
ease burden than a large shift among those persons
already at high risk. Thus greater health benefits can
be achieved if preventive efforts are focused on the
whole populations rather than mainly on high-risk indi-
viduals. Traditional approaches to epidemiology and
individual interventions have produced major advances
in elucidating the relationship between risk factors and
disease outcomes. However, efficacious treatments at
an individual level may flounder when scaled up
beyond individual intervention to population-level
efforts directed to several thousands of individuals.25
Socioecological theories have identified the relation-
ships between different levels of determinants for
chronic disease and consistently show that individual
behaviour is nested within a number of other layers.
CVD risk has, therefore, been variably depicted as the
presence of lesions on an artery wall, blood levels of
lipids, unhealthy diet and low physical activity, expos-
ure to unhealthy food environments, dangerous neigh-
bourhoods for active transport and urban planning,
poverty, state and federal planning policy, and the
implications of international trade agreements. These
factors can be described as an axis of nested hierarchies
from the micro level (e.g. individual choice, family
influence) through the mezzo level (e.g. workplace,
health care) and macro level (e.g. policy at state, city,
or regional level) to global level (e.g. national policies
and implications of international trade).26
While the personalized strategies will focus on the
micro level, the population-based preventive strategies
should focus on mezzo, macro, and global levels.
Population-based strategies include fiscal measures
(i.e. taxation and subsidies), international, national,
and regional policy and legislation (e.g. smoke-free
policies, rules for marketing, food production), and
environmental changes. All strategies for changing
risk factors, therefore, need to consider the interaction
between levels and how policy change at national level
shifts individual risk behaviour.27,28
Several stakeholders at different levels are concerned
for each of the factors addressed in this position paper:
. international level (WHO, WTO, EU)
. national level (government department, health
authorities, health agencies, industries)
. regional level (relevant authorities, such as for traffic
planning, schools, construction of public buildings).
Responsibility should be shared between politicians,
administrative authorities, health professionals, and
NGOs. They should scrutinize the balance between
health and profit, and be aware of conflicts of interests
with industries.29 Communication to the general public
should thus be the responsibility of health authorities,
not industry.30,31 Mass media campaigns and indivi-
dualized interventions to change behaviour can
improve health, but are more likely to be effective if
complementary policy or legal frameworks are in
place making the healthy choices the easy choices.32
The diffusion of internet networks may obviously rep-
resent an opportunity.
Recommendations and actions
Food
Changing dietary patterns from unhealthy to healthy
and lowering daily total energy intake will substantially
lower cardiovascular risk.4,33,34 Diet is a very complex
area in the cross field between personal choices, pro-
duction, and marketing. Healthy food policies should
aim to facilitate and incentivize positive interactions
between governments, industry, and wider society to
collaborate in achieving substantial reductions in CVD.
International level
WHO recommends salt intake to be less than
5 g/day, both saturated fat and free sugar to comprise
less than 10% of total energy, and elimination of
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industrially produced trans-fats (TFA).35,36 There is
growing awareness of the potential benefits of policy
intervention in the agricultural sector to influence
agricultural production practice.37 EU Common
Agricultural Policy (CAP) and food systems have sup-
ported unhealthy diets. Future CAP reforms should,
therefore, include public health nutrition in its object-
ives, e.g. by supporting a shift from meat and dairy
products to fruit and vegetables.38–40
National level
Pricing. Taxation of unhealthy food is estimated to
reduce CVD death in UK by perhaps 2%.41 Taxation
of sugar, fat, and salty foods are implemented in some
countries.34 In the USA, soda taxes are implemented in
14 states.14 No substantial knowledge of the effect on
consumption or obesity exist,42 but tax is often lowered
due to lobbying from industries.43
Subsidies for fruit and vegetables increase affordabil-
ity.44 The EU school fruit scheme has been widely
adopted, with some benefit.45 Agricultural subsidies
have been successful in Finland helping farmers to
make substantial shifts from meat and dairy to oil,
seed, and berry production.46,47
Restriction/availability. Several countries have devel-
oped guidelines to reduce salt to below 6 g/day,12
though relatively few have gone beyond policy state-
ments.48 Eighty percent of salt intake stems from the
processed food industry12 and increasing successes have
followed pressure on food industry and governments.49
Legislative measures were effective in reducing salt in
Finland (from 14 to 9 g/day), and other countries have
followed.50 In contrast, voluntary agreements involving
collaboration with food companies have achieved smal-
ler reductions, e.g. UK (from 9.5 to 8.6 g/day).4
Modelling studies in USA,51 UK,52 and Australia53
have consistently suggested that salt reduction is
powerful and cost-saving. Legislation for salt reduction
may be 20 times more effective than voluntary
schemes.53
Legislation to remove industrial trans-fatty acid
(TFAs) has been successfully implemented in
Denmark, Sweden, Iceland, Austria, Switzerland,
Seattle, and New York.36 Voluntary schemes are
reducing TFA intakes more slowly in UK and
Netherlands.4,36 Data on the effect on CVD are awaited.
Advertising of junk food (food high in fat, salt, and
sugar). Restriction may be very efficient.54,55 In the
UK, the Office of Communication (OFCOM) banned
any TV advertising of food high in fat, salt, and sugar
(HFSS) aimed at children, where they make up more
than 60% of the audience.54,56 Exposure fell by about
one-third in 2007/08 compared to 2005. Data on actual
changes in HFSS intake are needed.54,56
Labelling. This aims to increase consumer informa-
tion, inform consumer choice, and pressure manu-
facturers to reformulate. Traffic light schemes are
consistently effective and preferred by consumers
in diverse jurisdictions across Europe, USA, and
Australia.57,58 The UK Food Standards Agency recom-
mended traffic lights, but industry lobbying resulted in a
more complex hybrid scheme. In the Netherlands, a
‘Healthy choice logo’ for recommended ‘basic’ products
and ‘Conscious choice logo’ for non-basic products
was introduced. The Nordic Council of Ministers
has endorsed a keyhole symbol indicating healthy food
items.59 Additional data on the effect of labelling on
changes in availability and in purchasing are needed.
Regional level
Restrictions/availability. Some countries have devel-
oped and promoted nutritional criteria for schools
through government or local policies e.g. UK School
Food Trust and Caroline Walker Trust.60 Vending
machines for confectionery and soft drinks were seen
in less than 5% in primary schools in Denmark.61 Other
countries are now banning such vending machines
(France, UK, USA). Singapore regulated vending
machines and gave access to water coolers resulting in
decrease in obesity.62 It is important that schools avoid
economic dependency on vending machines. HFSS
food and snacks in schools also need control.45
Controlling the number of fast food restaurants near
schools appears potentially useful.63 A borough in
London (Barking and Dagenham) recently won a
legal victory supporting a policy restricting takeaways
near schools. Data on the effect of these regulations on
HFSS intake among school children is needed.44
Healthy food initiatives in public and workplace
canteens were started in the North Karelia program
then rolled out across Finland.64 In 2008, Los
Angeles banned new fast-food outlets to reduce obesity.
The coverage of the ban was weak and there is uncer-
tainty about any effect.65
Smoking
Any reduction in smoking and second-hand smoke
exposure will lead to reduced cardiovascular morbidity
and mortality. Although smoking prevalence is declin-
ing, the decline is less evident in lower socioeconomic
groups and underreporting is increasing.66 There is no
safe level of second-hand smoke exposure and a com-
pletely smoke-free environment is the only way to pro-
tect non-smokers. Voluntary policies, separate smoking
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rooms, and improved ventilation do not reduce second-
hand exposure to an acceptable level.67,68
International level
The WHO Framework Convention on Tobacco
Control (FCTC) has specified recommendations
for the implementation of national, comprehensive
smoke-free laws, currently adopted by more than 170
countries.69 However, in several countries legislation
offers only limited protection or laws are not enforced.
To avoid border sales, harmonization of excise duties at
a high level within the EU should be pursued.70
National level
Pricing. For each 10% increase in retail prices,
tobacco consumption is reduced by 4% in high-
income and 8% in low- and middle-income countries.
Teenagers and poor are more sensitive to increased tax-
ation with 2–3-fold higher probability of quitting after
price increases.71–73
Restrictions. Adolescents do not worry about health
consequences of smoking and are more susceptible to
peer pressure and advertising. Several studies with com-
munity-level intervention have shown that restrictions
on adolescents’ access to tobacco leads to reduced smok-
ing prevalence.74–76 Restriction on retail aimed at youth
would include banning of tobacco vending machines.
Restrictions on retail sale for adults, as implemented in
some countries for alcohol, have not been studied.
Smoking bans in the public domain led to reduction in
exposure to passive smoking and an estimated 17%
reduction in incidence of myocardial infarction,77,78
while it is less clear whether legislation also leads to
smoking cessation in the general population.79
Labeling. One of the best ways to raise awareness of
the dangers of tobacco is through the adoption of large
mandatory pictorial warnings on the pack. Although
pictorial and text health warnings have been shown to
increase perception of risk and to reduce smoking
uptake, changes cannot be attributed to labelling
alone.80 Health warnings have greater impact in coun-
tries with more comprehensive tobacco control pro-
grammes and in smokers with lower socioeconomic
status.81 To enhance effectiveness of pictorial warnings,
they must be combined with plain, standardized
packaging.70,82–86
Advertising. Exposure to advertising is associated
with increased likelihood that in particular adolescents
will take up smoking.87 A complete ban of all advertis-
ing and marketing may lead to 7% reduction in tobacco
consumption, whereas partial banning of advertising
has little if any effect on smoking prevalence.88
Media campaigns. TV campaigns may reduce smok-
ing uptake by teenagers and increase quit rates among
adults.89,90 Based on few and heterogeneous studies, a
Cochrane review concluded that mass media campaigns
may have an effect on smoking behaviour in adults,91
whereas anti-tobacco campaigns directed at youth in
schools have not reduced initiation.92,93
Regional level
Restriction. Smoking bans at workplaces have lead
to reductions in exposure to passive smoking, in par-
ticular among hospitality workers, decreased cigarette
consumption during the working day, and higher
smoking cessation rates.94,95 Restrictions on smoking
in general may enhance a cultural shift towards ‘denor-
malization’ of smoking, as a high public support for
and compliance with smoking bans has been seen
after passing legislation.79 Smoke-free policies at work-
ing sites can provide substantial saving to employers as
well as health benefits for the former tobacco user95
without harming business in restaurants and bars.96–98
Physical inactivity
Any increase in daily physical activity and decrease in
sedentary time will reduce CVD morbidity and mortal-
ity.18,99,100 Trends go towards integrating physical
activity into daily life activities such as reducing sitting
time99 and promoting active commuting as cycling and
walking to work. A simulation study showed that
change in environment to support more active lifestyle
was cost-effective.101 Public perception of the import-
ance of physical activity is still relative low in some
countries, e.g. Croatia.102
Reviews103,104 and reports105–107 have summarized
the available evidence on how to promote and create
built or natural environments that encourage and sup-
port physical activity. A recent Cochrane review108 con-
cluded that there is a noticeable inconsistency of the
findings of available studies and that there is a clear
need for future well-designed intervention studies. The
review mixes the effect of individualized intervention
with mass campaigns and (seldom) structural changes,
which makes it difficult to delimitate the effect of struc-
tural changes.
International level
Recommendations at population levels are to change
environments that facilitate physical activities, which fit
into daily routine making it easier for people to follow
414 European Journal of Preventive Cardiology 20(3)
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the current guidelines, which includes moderate-inten-
sity activities (e.g. brisk walking) for a minimum of 30
minutes on 5 days/week or vigorous-intensity activities
(e.g. jogging) for a minimum of 25 minutes on 3 days/
week, or a combination of both.109
National and regional level
Pricing. Taxing private motor transport with intro-
duction or road-user charges and higher parking fees
together with cheaper public transport can support
physically active modes of transport.105
Restriction/availability. A re-allocation of road space
by introducing cycle and footpath lanes, closing or nar-
rowing roads in city, and creating or enhancing places
for physical activity is beneficial.103
Linkage of different sites (e.g. homes, schools) by
appropriate walking and cycling networks (trail con-
nectivity) including safe routes to schools will facilitate
walking and cycling.105,107 Use of staircases rather than
elevators and escalators can be encouraged as default
by good visibility and signposting.110 Designing school
playgrounds so that they encourage varied physically
active play combined with it being compulsory to be in
the schoolyard during lesson breaks will facilitate phys-
ical activity.111
Encouragement of employees to walk, cycle, or use
other modes of transport involving physical activity in
travel to and from work and as part of their working
day.106 Finally, introduction of systematic breaks in
sitting time is a promising new effort.99,106
Alcohol
Although ‘light-to-moderate’ alcohol consumption may
be beneficial in CVD prevention, the message is often
interpreted inappropriately. Excessive alcohol intake
is clearly associated with increased cardiovascular
mortality21 and alcohol ranks as the second-leading
cause of DALYs lost in high-income countries.112
Recommending of alcohol consumption for non-
drinking persons is therefore not supported.
International level
WHO and EU recommend taxation, low legal limits
for alcohol concentrations in blood for drivers, min-
imum age for purchasing alcohol, and regulation of
availability.30,113
National level
Pricing. A huge literature establishes that for each
10% increase in retail price, alcohol consumption is
reduced by 5.1%, ranging from 4.6% for beer to
8.0% for spirits.114
Restriction. Age limits for sale and serving with con-
sequences for shops and restaurant that violate the
rules are effective.115–117 Various drink-driving strate-
gies are very effective in reducing numbers of persons
driving after drinking alcohol,118,119 which may have an
indirect effect on the overall consumption of alcohol.
Government retail monopolies for sale of alcohol can
reduce alcohol-related harm due to restriction in the
number of outlets for alcohol purchase; furthermore
reducing the hours of sale of alcohol has shown bene-
ficial effect.120
Labelling. Labelling alcohol with information on cal-
oric content and health warning messages of the harm-
ful effects of alcohol has shown limited effect.121
Advertising. Alcohol advertising, promotion, and
sponsorship of events is clearly related to initiation of
young drinking, and it seems as if the effect of exposure
is dose related and cumulative over time.116 This could
support that banning alcohol advertising would be
effective in reducing consumption.
Regional level. Alcohol regulations in policies on work-
places, educational centres, and schools are effective,
whereas education of the harmful effect of alcohol in
schools have no effect,116 which is the preferred recom-
mendation of the alcohol industry.116
Discussion
Societal changes during the last decades have led to the
present harmful environment with high calorie intake,
low degree of physical activity, continuous smoking,
and high alcohol intake. As systematic screening and
multifactorial individualized intervention is insufficient
in changing CVD risk at a population level,25 a struc-
tural approach is called for. This paper shows several
initiatives at international, national, and regional levels
that can contribute to reduction in CVD.
Besides strategies including taxation, subsidies, and
statutory regulation, strategies such as ‘nudging’ and
‘default’ have been proposed as tools.122,123 Nudge –
to push mildly – can be done by setting the default to
healthy. A default is an option that will be obtained if
the chooser does nothing, so a large number of people
will end up with that option, whether or not it is good
for them. This is the way that advertising and space
management in supermarkets work. Therefore, a task
for both national and local authorities is to regulate
society to the more healthy default. This was launched
by WHO in 1986 – ‘making the healthy choices the
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easy choices’.124 However, policies to promote healthy
lifestyle routinely face opposition by commercial vested
interest from corporations (e.g. food, tobacco, alcohol)
and health authorities need to anticipate this conflict of
interest in their attempt to change the CVD
risk.29,31,125,126
Opponents allege that the ‘nanny state’ hinders the
free choice of people,122,127 but the fact is that people
today are nudged in the wrong direction by corpor-
ations’ de facto setting of the default option.123 Yet,
corporations do not have responsibility for population
health – this is the responsibility of governments, which
have a duty of care, already acknowledged in respect to
public health successes including clean water and air,
sanitation, and traffic regulation. For example, redu-
cing air pollution is a prioritized area in Europe with
the 6th Environment Action Programme128,129 based
on the Clean Air for Europe programme130 and the
WHO guidelines for air quality.128 The average expos-
ure index (AEI) of PM2.5 in European countries (2007)
varies from about 10 yg/m3 in Ireland and Finland to
above 30 mg/m3 in Bulgaria and Romania.131 Estimates
show that with a reduction in PM2.5 to 6 yg/m3 mor-
tality for cardiopulmonary diseases and lung cancer will
be reduced by 17%.132 Changes from private cars to
public transport and better facilities for physical
active modes of transport will both increase physical
activity and reduce pollution.
It is only natural to extend these well-established
responsibilities to create healthy societies.124 The free-
dom of choice will remain, so people still can make the
unhealthy choices. But as most people want the healthy
choice, a more healthy default will help in lowering the
CVD risk. New media, which can be used to promote
unhealthy behaviours, could instead generate institu-
tional strategies at national level to support healthier
individual behaviours.133
Social inequality in health is increasing134 and is exa-
cerbated by a predominant focus on individualized pre-
vention.122 There is a concern about the impact of
psychosocial factors including chronic stress and lack
of social network influencing the burden of CVD, but
the knowledge of which interventions are effective is
sparse.135 WHO recommends making social support
in stress prevention an important goal for communities
and managers.136 The structural changes mentioned in
this presentation seem to have the potential to decrease
social inequality in health.122
Population interventions tend to work quickly77,78
and to be cost saving.53,73,101 Structural changes to
avoid chronic diseases are now favoured from several
sides.137 The growing literature of the possible impact
of structural strategies on health signals a paradigm
shift in CVD prevention. Small changes in the whole
society – changes that will not be dramatic for the single
citizen – will substantially change the risk of CVD
according to Rose’s preventive paradox.24 A report
from the National Institute of Clinical Excellence
(NICE) have estimated that a UK national programme
reducing population cardiovascular risk by 1% would
prevent 25,000 CVD cases and generate savings of E40
million per annum. Reducing mean population choles-
terol or blood pressure by 5% would result in annual
savings exceeding E100 million.4 A WHO bulletin
report suggests that CHD mortality rates easily could
be halved by modest risk factor reduction138 and that
Box. Population level changes to prevent CVD: main conclusions and recommendations
 CVD causes more than 4.3 million annual death in Europe and costs at least 190 billion E.
 Important modifiable risk factors for CVD (unhealthy diet, smoking, alcohol, and physical inactivity) all respond to structural
changes in society.
 Population level interventions aim at small changes in the whole population, which can have a higher impact on overall CVD burden
than changes among high-risk individuals.
 Responsibility for structural changes should be shared between politicians, administrative authorities, and health professionals.
Changes should be at international, national, and local levels.
 Healthy dietary habits will be supported by changes in agricultural policies, tax on products with free sugar and saturated fat and
subsidies for fruit and vegetables, reduction of salt and trans-fatty acids in processed foods, clear labelling of foods, and limiting
advertising for junk food.
 Completely smoke-free environments are the only way to protect non-smokers. Smoking and second-hand smoking can be
regulated by taxation, restrictions in sale and use, banning advertising, plain packaging, and warning labels.
 Physical activities should be integrated in daily life by subsidies to public transport and re-allocating of road space to cycle and
footpath lanes. Changes in schools, worksites, and built environment can make physical activity a more natural part of daily life.
 Alcohol intake can be reduced by taxation, low availability, regulation of advertising, and low social and legal tolerance of drink
driving.
 It is estimated that such population-level changes can halve CVD mortality rates.
 In a complex, modern society there is an interaction between personal choices, production and marketing. To secure a real free
choice for citizens, health authorities need to ensure healthy defaults, thus balancing the vested interests of corporations, who are
not responsible for public health.
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improved diet alone could halve CVD death.34 The
question has been raised whether structural changes
with a slight reduction over the whole spectre of CVD
risk is more efficient than a high-risk strategy using, for
example, the polypill (consisting of cholesterol-lower-
ing, antihypertensive, and antiplatelet agents).139–142
Adapting the polypill approach includes screening
with detection of high-risk persons, initiation of treat-
ment and compliance, which will never reach 100%.
And even if the 100% compliance was reached, it has
been estimated that the population approach seems to
be more effective.143 The polypill should be reserved for
people at high risk if its efficacy and safety is demon-
strated. In general, population-based and high-risk
strategies should be used complementarily.
Much research needs to be done, but the structural
strategies represent a powerful and cost-effective strat-
egy, which so far has been underestimated.
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